The Use of Biomarkers in Clinical Trials for Patient Stratification, & Supporting Key Efficacy & Safety Outcomes
Time: 1:30 pm
day: Day Two
Details:
- Sharing biomarker-driven enriched patient enrollment and/or clinical data
- Discussing biomarker-supported product differentiation of clinical efficacy and safety
- Reviewing pharmacoeconomics and biomarker-aided pricing and reimbursement strategies, specifically